首页> 美国卫生研究院文献>Journal of Thoracic Disease >Successful treatment of gefitinib-induced acute interstitial pneumonitis with corticosteroid and non-invasive BIPAP-ventilation
【2h】

Successful treatment of gefitinib-induced acute interstitial pneumonitis with corticosteroid and non-invasive BIPAP-ventilation

机译:皮质类固醇和无创BIPAP通气成功治疗吉非替尼诱导的急性间质性肺炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This is the case of a 63 year-old male who was diagnosed adenocarcinoma in the left upper lung with ipsilateral malignant pleural effusion. At diagnosis it had already spread to left pulmonary HLN (hilar lymph node) and left supraclavicular lymph node and mediastinal lymph nodes. The patient received combined chemotherapy with bevacizumab and GP (gemcitabine and carboplatin) for 6 courses. Disease progression on chest CT scan was recognized, daily treatment with oral gefitinib (250 mg/day) was commenced. One week later, he was admitted under the impression of gefitinib-related interstitial pneumonitis, gefitinib was discontinued immediately and methylprednisolone with BIPAP assisted ventilation were used. The patient was followed up for 2 months after the start of treatment with corticosteroids and BIPAP assisted ventilation and remained well.
机译:这是一名63岁的男性,在左上肺被诊断出患有同侧恶性胸腔积液的腺癌。在诊断时,它已经扩散到左肺HLN(肺门淋巴结)以及左锁骨上淋巴结和纵隔淋巴结。该患者接受了贝伐单抗和GP(吉西他滨和卡铂)联合化疗6个疗程。胸部CT扫描已确认疾病进展,开始使用口服吉非替尼(250 mg /天)进行每日治疗。一周后,他因吉非替尼相关的间质性肺炎而入院,吉非替尼立即停药,并使用甲基泼尼松龙联合BIPAP辅助通气。开始用皮质类固醇和BIPAP辅助通气治疗后,对患者进行了2个月的随访,并保持良好状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号